Prognostic study of risk reduction among Japanese ischemic heart disease patients with coronary revascularization using quantitative analysis of gated myocardial perfusion SPECT

Prognostic study of risk reduction among Japanese ischemic heart disease patients with coronary revascularization using quantitative analysis of gated myocardial perfusion SPECT - Multicenter study for assessment of usefulness of gated myocardial perfusion SPECT in patients receiving revascularization therapy (J-ACCESS4)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008050

Enrollment

500

Registered

2012-05-31

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Ischemic heart disease (IHD) patients (include suspected IHD and history of revascularization) with at least one of following symptom/findings 1)Angina or equivalent chest pain 2)Suspected IHD due to newly shortening of breath/ palpitation 3)Findings of IHD by ECG (2)Patient>=20 years old and received written informed consent (3)SPECT study performed indicated time period

Exclusion criteria

Exclusion criteria: (1)ACS patient within 3 months prior to registration (2)History of old myocardial infarction with following category 1)History of higher cardiac enzyme(CK or CK-MB more than twice of normal level or elevation of Troponin) 2) Finding of new Q wave by more than adjacent 2 lead by ECG 3) Certified non viable myocardium by cardiac imaging test (3)patients with dialysis or peritoneal dialysis (4)valvular disease necessary to surgical therapy (5) Also diagnosed HCM or DCM (6) Heart failure >= NYHA3 (7)Difficult to study Gated SPECT due to arrhythmia (8) Drug hypersensitivity with Tetrofosmin or analogous drug (9)Unsuitable for registration by investigator

Design outcomes

Primary

Measure	Time frame
Cardiac death, Sudden death, Non-cardiac death, Hospitalization of heart failure	—

Secondary

Measure	Time frame
Non fatal myocardial infarction, Hospitalization for unstable angina, Stroke, Coronary or peripheral artery infarction, Receiving PCI or CABG	—

Countries

Japan

Contacts

Public ContactKenji Ichioka

Japan Cardiovascular research foundation J-ACCESS office

jimu@j-access.jp06-6155-1003

Outcome results